SHANNON ONSTOTT: Open Payments
NPI 1851780191 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,704 in 90 payments from 16 companies in 2025. Trend: 2023 $1,435 · 2024 $1,543 · 2025 $1,704
Food & beverage: $1,704
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $268 |
| Organogenesis Inc. | 4 | $248 |
| Novartis Pharmaceuticals Corporation | 12 | $210 |
| Regeneron Healthcare Solutions, Inc. | 13 | $183 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $170 |
| ABBVIE INC. | 11 | $163 |
| Lilly USA, LLC | 5 | $95 |
| LEO Pharma Inc. | 5 | $80 |
| UCB, Inc. | 5 | $70 |
| GENZYME CORPORATION | 3 | $53 |
Products named: TREMFYA, COSENTYX, DUPIXENT, AFFINITY, ILUMYA, SKYRIZI, TALTZ, NOVACHOR.
Industry payments across IN — which companies pay providers there.
